Roberto G. Carbone

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article may require copy editing for grammar, style, cohesion, tone, or spelling. You can assist by editing it. (July 2024) (Learn how and when to remove this message) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Roberto G. Carbone" – news · newspapers · books · scholar · JSTOR (August 2024) (Learn how and when to remove this message) (Learn how and when to remove this message)

Roberto G. Carbone (born in Genoa, Italy - 6 September 1954) is an Italian scientist and clinician, studying the mechanisms and treatment of pulmonary fibrosis such as extracellular matrix with Annie Pardo Cemo and Moisés Selman-Lama, Global idiopathic pulmonary fibrosis genome, discoverer of pulmonary hypertension as the most important cause of mortality in cardiopulmonary diseases, as confirmed by Prof. Robert P. Baughman, University of Cincinnati with whom he studied the pathophysiology, diagnosis and therapy of sarcoidosis. Furthermore he collaborated with D. Geraint James regarding the treatment of sarcoidosis. He also an expert in lung transplantation, lung cancer mechanisms, asbestosis and mesothelioma.^[1] He also studied the role of neuropeptides (neurotensin) in asthma adrenergic and recently his research focused on stem cells post acute myocardial infarction (AMI)^[2]